Five-year cumulative incidence of dementia by baseline age and APOE-e4 dose.

APOE 4 allele predicts faster cognitive decline in mild Alzheimer disease

S. Cosentino Phd
N. Scarmeas Md
E. Helzner Phd
M. M. Glymour Phd
J. Brandt Phd
M. Albert Phd
D. Blacker
Y. Stern Phd

August 2015

Objective: To determine whether APOE 4 predicts rate of cognitive change in incident and prev-alent ...

Cognitive Performance over Time and APOE4 in Non-Demented Oldest-Old

Balasubramanian, Archana
Kawas, Claudia
Peltz, Carrie
Corrada-Bravo, Maria

April 2012

Abstract Objective: To determine if cognitive performance over time is related to the APOE4 allele i...

Incidence of Dementia in Relation to Stroke and the Apolipoprotein E e4 Allele in the Very Old Findings From a Population-Based Longitudinal Study

October 2016

Background and Purpose—Both stroke and the apolipoprotein E (APOE) e4 allele increase the risk of de...

Five-year cumulative incidence of mild cognitive impairment/dementia by baseline age and APOE-e4 dose.

Jing Qian (170232)
Frank J. Wolters (3208329)
Alexa Beiser (540215)
Mary Haan (3850348)
M. Arfan Ikram (135636)
Jason Karlawish (140210)
Jessica B. Langbaum (3850345)
John M. Neuhaus (3850354)
Eric M. Reiman (295549)
J. Scott Roberts (3850342)
Sudha Seshadri (79956)
Pierre N. Tariot (3850339)
Beth McCarty Woods (3850351)
Rebecca A. Betensky (442911)
Deborah Blacker (28889)

March 2017

Five-year cumulative incidence of mild cognitive impairment/dementia by baseline age and APOE<...

Lifetime (to age 80–85 y) cumulative incidence of dementia by baseline age and APOE-e4 dose.

Jing Qian (170232)
Frank J. Wolters (3208329)
Alexa Beiser (540215)
Mary Haan (3850348)
M. Arfan Ikram (135636)
Jason Karlawish (140210)
Jessica B. Langbaum (3850345)
John M. Neuhaus (3850354)
Eric M. Reiman (295549)
J. Scott Roberts (3850342)
Sudha Seshadri (79956)
Pierre N. Tariot (3850339)
Beth McCarty Woods (3850351)
Rebecca A. Betensky (442911)
Deborah Blacker (28889)

March 2017

Lifetime (to age 80–85 y) cumulative incidence of dementia by baseline age and APOE-e4 dos...

Qian, J. (Jing)
Wolters, Frank
Beiser, Alexa
Haan, M. (Mary)
Ikram, Kamran
Karlawish, J. (Jason)
Langbaum, J.B. (Jessica B.)
Neuhaus, J.M. (John M.)
Reiman, Eric
Roberts, Scott
Seshadri, Sudha
Tariot, P.N. (Pierre N.)
Woods, B.M. (Beth McCarty)
Betensky, R.A. (Rebecca A.)
Blacker, Deborah

March 2017

textabstractBackground: With the onset of prevention trials for individuals at high risk for Alzheim...

Qian, Jing
Wolters, Frank J
Beiser, Alexa
Haan, Mary
Ikram, M Arfan
Karlawish, Jason
Langbaum, Jessica B
Neuhaus, John M
Reiman, Eric M
Roberts, J Scott
Seshadri, Sudha
Tariot, Pierre N
Woods, Beth McCarty
Betensky, Rebecca A
Blacker, Deborah

January 2017

BackgroundWith the onset of prevention trials for individuals at high risk for Alzheimer disease, th...

Qian, Jing
Wolters, Frank J.
Beiser, Alexa
Haan, Mary
Ikram, M. Arfan
Karlawish, Jason
Langbaum, Jessica B.
Neuhaus, John M.
Reiman, Eric M.
Roberts, J. Scott
Seshadri, Sudha
Tariot, Pierre N.
Woods, Beth McCarty
Betensky, Rebecca A.
Blacker, Deborah

March 2017

Background With the onset of prevention trials for individuals at high risk for Alzheimer disease, t...

Qian, Jing
Wolters, Frank J
Beiser, Alexa
Haan, Mary
Ikram, M Arfan
Karlawish, Jason
Langbaum, Jessica B
Neuhaus, John M
Reiman, Eric M
Roberts, J Scott
Seshadri, Sudha
Tariot, Pierre N
Woods, Beth McCarty
Betensky, Rebecca A
Blacker, Deborah

March 2017

BackgroundWith the onset of prevention trials for individuals at high risk for Alzheimer disease, th...

The estimated transition probability matrix of clinical dementia rating (CDRGLOB) in Alzheimer's disease patients at the age of 55 or 85 and carrying no, one, or two APOE- 4 alleles.

Wei Liu (20030)
Bo Zhang (6559)
Zhiwei Zhang (12077)
Xiao-Hua Zhou (345533)

September 2013

The estimated transition probability matrix of clinical dementia rating (CDRGLOB) in Alzheimer's ...

Qian, Jing
Wolters, Frank J
Beiser, Alexa
Haan, Mary
Ikram, M Arfan
Karlawish, Jason
Langbaum, Jessica B
Neuhaus, John M
Reiman, Eric M
Roberts, J Scott
Seshadri, Sudha
Tariot, Pierre N
Woods, Beth McCarty
Betensky, Rebecca A
Blacker, Deborah

March 2017

BackgroundWith the onset of prevention trials for individuals at high risk for Alzheimer disease, th...

The cumulative incidence of dementia estimated by Kaplan–Meier method for patients with oxybutynin, solifenacin or tolterodine exposure

Yu-Wan Yang (710822)
Hsin-Ho Liu (710824)
Tien-Huang Lin (631773)
Hsun-Yang Chuang (2589691)
Tengfu Hsieh (2937942)

April 2017

The cumulative incidence of dementia estimated by Kaplan–Meier method for patients with oxybutyni...

Qian, Jing
Wolters, Frank J.
Beiser, Alexa
Haan, Mary
Ikram, M. Arfan
Karlawish, Jason
Langbaum, Jessica B.
Neuhaus, John M.
Reiman, Eric M.
Roberts, J. Scott
Seshadri, Sudha
Tariot, Pierre N.
Woods, Beth McCarty
Betensky, Rebecca A.
Blacker, Deborah

May 2017

Background: With the onset of prevention trials for individuals at high risk for Alzheimer disease, ...

The estimated transition probability matrix of binary cognitive status measured by COGSTAT in Alzheimer's disease patients at the age of 55 or 85, having 12 or 20 years of eduction, and carrying no, one, or two APOE- 4 alleles.

Wei Liu (20030)
Bo Zhang (6559)
Zhiwei Zhang (12077)
Xiao-Hua Zhou (345533)

September 2013

The estimated transition probability matrix of binary cognitive status measured by COGSTAT in Alz...

APOE Epsilon 4 Allele Predicts Faster Cognitive Decline in Mild Alzheimer Disease

Cosentino, Stephanie
Scarmeas, Nikolaos
Helzner, Elizabeth P.
Glymour, M. Maria
Brandt, Jason
Albert, Marilyn
Blacker, Deborah
Stern, Yaakov

January 2008

OBJECTIVE: To determine whether APOE epsilon 4 predicts rate of cognitive change in incident and pre...

APOE 4 allele predicts faster cognitive decline in mild Alzheimer disease

S. Cosentino Phd
N. Scarmeas Md
E. Helzner Phd
M. M. Glymour Phd
J. Brandt Phd
M. Albert Phd
D. Blacker
Y. Stern Phd

August 2015

Objective: To determine whether APOE 4 predicts rate of cognitive change in incident and prev-alent ...

Cognitive Performance over Time and APOE4 in Non-Demented Oldest-Old

Balasubramanian, Archana
Kawas, Claudia
Peltz, Carrie
Corrada-Bravo, Maria

April 2012

Abstract Objective: To determine if cognitive performance over time is related to the APOE4 allele i...

Incidence of Dementia in Relation to Stroke and the Apolipoprotein E e4 Allele in the Very Old Findings From a Population-Based Longitudinal Study

October 2016

Background and Purpose—Both stroke and the apolipoprotein E (APOE) e4 allele increase the risk of de...

Five-year cumulative incidence of mild cognitive impairment/dementia by baseline age and APOE-e4 dose.

Jing Qian (170232)
Frank J. Wolters (3208329)
Alexa Beiser (540215)
Mary Haan (3850348)
M. Arfan Ikram (135636)
Jason Karlawish (140210)
Jessica B. Langbaum (3850345)
John M. Neuhaus (3850354)
Eric M. Reiman (295549)
J. Scott Roberts (3850342)
Sudha Seshadri (79956)
Pierre N. Tariot (3850339)
Beth McCarty Woods (3850351)
Rebecca A. Betensky (442911)
Deborah Blacker (28889)

March 2017

Five-year cumulative incidence of mild cognitive impairment/dementia by baseline age and APOE<...

Lifetime (to age 80–85 y) cumulative incidence of dementia by baseline age and APOE-e4 dose.

Jing Qian (170232)
Frank J. Wolters (3208329)
Alexa Beiser (540215)
Mary Haan (3850348)
M. Arfan Ikram (135636)
Jason Karlawish (140210)
Jessica B. Langbaum (3850345)
John M. Neuhaus (3850354)
Eric M. Reiman (295549)
J. Scott Roberts (3850342)
Sudha Seshadri (79956)
Pierre N. Tariot (3850339)
Beth McCarty Woods (3850351)
Rebecca A. Betensky (442911)
Deborah Blacker (28889)

March 2017

Lifetime (to age 80–85 y) cumulative incidence of dementia by baseline age and APOE-e4 dos...

Qian, J. (Jing)
Wolters, Frank
Beiser, Alexa
Haan, M. (Mary)
Ikram, Kamran
Karlawish, J. (Jason)
Langbaum, J.B. (Jessica B.)
Neuhaus, J.M. (John M.)
Reiman, Eric
Roberts, Scott
Seshadri, Sudha
Tariot, P.N. (Pierre N.)
Woods, B.M. (Beth McCarty)
Betensky, R.A. (Rebecca A.)
Blacker, Deborah

March 2017

textabstractBackground: With the onset of prevention trials for individuals at high risk for Alzheim...

Qian, Jing
Wolters, Frank J
Beiser, Alexa
Haan, Mary
Ikram, M Arfan
Karlawish, Jason
Langbaum, Jessica B
Neuhaus, John M
Reiman, Eric M
Roberts, J Scott
Seshadri, Sudha
Tariot, Pierre N
Woods, Beth McCarty
Betensky, Rebecca A
Blacker, Deborah

January 2017

BackgroundWith the onset of prevention trials for individuals at high risk for Alzheimer disease, th...

Qian, Jing
Wolters, Frank J.
Beiser, Alexa
Haan, Mary
Ikram, M. Arfan
Karlawish, Jason
Langbaum, Jessica B.
Neuhaus, John M.
Reiman, Eric M.
Roberts, J. Scott
Seshadri, Sudha
Tariot, Pierre N.
Woods, Beth McCarty
Betensky, Rebecca A.
Blacker, Deborah

March 2017

Background With the onset of prevention trials for individuals at high risk for Alzheimer disease, t...

Qian, Jing
Wolters, Frank J
Beiser, Alexa
Haan, Mary
Ikram, M Arfan
Karlawish, Jason
Langbaum, Jessica B
Neuhaus, John M
Reiman, Eric M
Roberts, J Scott
Seshadri, Sudha
Tariot, Pierre N
Woods, Beth McCarty
Betensky, Rebecca A
Blacker, Deborah

March 2017

BackgroundWith the onset of prevention trials for individuals at high risk for Alzheimer disease, th...

The estimated transition probability matrix of clinical dementia rating (CDRGLOB) in Alzheimer's disease patients at the age of 55 or 85 and carrying no, one, or two APOE- 4 alleles.

Wei Liu (20030)
Bo Zhang (6559)
Zhiwei Zhang (12077)
Xiao-Hua Zhou (345533)

September 2013

The estimated transition probability matrix of clinical dementia rating (CDRGLOB) in Alzheimer's ...

Qian, Jing
Wolters, Frank J
Beiser, Alexa
Haan, Mary
Ikram, M Arfan
Karlawish, Jason
Langbaum, Jessica B
Neuhaus, John M
Reiman, Eric M
Roberts, J Scott
Seshadri, Sudha
Tariot, Pierre N
Woods, Beth McCarty
Betensky, Rebecca A
Blacker, Deborah

March 2017

BackgroundWith the onset of prevention trials for individuals at high risk for Alzheimer disease, th...

The cumulative incidence of dementia estimated by Kaplan–Meier method for patients with oxybutynin, solifenacin or tolterodine exposure

Yu-Wan Yang (710822)
Hsin-Ho Liu (710824)
Tien-Huang Lin (631773)
Hsun-Yang Chuang (2589691)
Tengfu Hsieh (2937942)

April 2017

The cumulative incidence of dementia estimated by Kaplan–Meier method for patients with oxybutyni...

Qian, Jing
Wolters, Frank J.
Beiser, Alexa
Haan, Mary
Ikram, M. Arfan
Karlawish, Jason
Langbaum, Jessica B.
Neuhaus, John M.
Reiman, Eric M.
Roberts, J. Scott
Seshadri, Sudha
Tariot, Pierre N.
Woods, Beth McCarty
Betensky, Rebecca A.
Blacker, Deborah

May 2017

Background: With the onset of prevention trials for individuals at high risk for Alzheimer disease, ...

The estimated transition probability matrix of binary cognitive status measured by COGSTAT in Alzheimer's disease patients at the age of 55 or 85, having 12 or 20 years of eduction, and carrying no, one, or two APOE- 4 alleles.

Wei Liu (20030)
Bo Zhang (6559)
Zhiwei Zhang (12077)
Xiao-Hua Zhou (345533)

September 2013

The estimated transition probability matrix of binary cognitive status measured by COGSTAT in Alz...

APOE Epsilon 4 Allele Predicts Faster Cognitive Decline in Mild Alzheimer Disease

Cosentino, Stephanie
Scarmeas, Nikolaos
Helzner, Elizabeth P.
Glymour, M. Maria
Brandt, Jason
Albert, Marilyn
Blacker, Deborah
Stern, Yaakov

January 2008

OBJECTIVE: To determine whether APOE epsilon 4 predicts rate of cognitive change in incident and pre...

APOE 4 allele predicts faster cognitive decline in mild Alzheimer disease

S. Cosentino Phd
N. Scarmeas Md
E. Helzner Phd
M. M. Glymour Phd
J. Brandt Phd
M. Albert Phd
D. Blacker
Y. Stern Phd

August 2015

Objective: To determine whether APOE 4 predicts rate of cognitive change in incident and prev-alent ...

Cognitive Performance over Time and APOE4 in Non-Demented Oldest-Old

Balasubramanian, Archana
Kawas, Claudia
Peltz, Carrie
Corrada-Bravo, Maria

April 2012

Abstract Objective: To determine if cognitive performance over time is related to the APOE4 allele i...

Incidence of Dementia in Relation to Stroke and the Apolipoprotein E e4 Allele in the Very Old Findings From a Population-Based Longitudinal Study

October 2016

Background and Purpose—Both stroke and the apolipoprotein E (APOE) e4 allele increase the risk of de...

Five-year cumulative incidence of dementia by baseline age and <i>APOE</i>-e4 dose.

Abstract

Extracted data

Five-year cumulative incidence of dementia by baseline age and <i>APOE</i>-e4 dose.

Abstract

Extracted data

Related items

Related items